Effect of antidiabetic drug classes on the risk of liver-related events in individuals with T2D and MASLD

Hepatology

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk

BMC Gastroenterol

Shin WY, Kang ES, Oh YH, Sha M, Xia Q, Jeong S, Cho Y

doi: 10.1186/s12876-025-03814-1

Hepatology

Association of Food Insecurity with the Prevalence and Liver-related Mortality of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

J Hepatol

Younossi ZM, Zelber-Sagi S, Kuglemas C, Lazarus JV, Paik A, de Avila L, Gerber L, Paik JM

doi: 10.1016/j.jhep.2024.08.011

Hepatology

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study

Am J Gastroenterol

Caviglia GP, Ferro A, D'Ambrosio R, Perbellini R, Lampertico P, Periti G, Valenti L, Ciccioli C, Pennisi G, Petta S, Brodosi L, Petroni ML, Marchignoli F, Pironi L, Sagripanti A, Argenziano ME, Svegliati-Baroni G, Rosso C, Barutta F, Armandi A, Gruden G, Bugianesi E

doi: 10.14309/ajg.0000000000003493

HepatologyFurther Publications

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

JAMA Intern Med

Kanwal F, Kramer JR, Li L, Yang YX, Cao Y, Yu X, Samuel R, Ali B, Desiderio R, Cholankeril G, Bajaj M, El-Serag HB, Asch SM

doi: 10.1001/jamainternmed.2024.4661

Hepatology

Effectiveness of six international guidelines using FIB-4 and FibroScan for risk stratification of MASLD in type 2 diabetes

Clin Gastroenterol Hepatol

Vidal-Trécan T, Julla JB, El Khoury T, Venteclef N, Riveline JP, Paradis V, Valla D, Gautier JF, Castera L

doi: 10.1016/j.cgh.2025.02.018

Gastrointestinal CancerHepatology

Primary liver cancer risk and mortality in patients with alcohol-related cirrhosis in England and Denmark: observational cohort studies

Am J Gastroenterol

Jensen MD, West PJ, Crooks C, Morling JR, Kraglund F, Card T, Askgaard G, Jepsen PP

doi: 10.14309/ajg.0000000000003077

Hepatology

Impact of MASLD and associated comorbidities on Cognitive and Health-related Quality of Life outcomes in a Mixed MASLD-T2DM Cohort

Am J Gastroenterol

Perez-Diaz-Del-Campo N, Castelnuovo G, Ferro A, Caviglia GP, Rosso C, Dileo E, Guariglia M, Armandi A, Saba F, Saracco GM, Barutta F, Beccuti G, Gruden G, Younossi ZM, Bugianesi E

doi: 10.14309/ajg.0000000000003594

Inflammatory Bowel Disease

Risk of age-related and disease-related complications and mortality in elderly-onset IBD - a population-based study

Clin Gastroenterol Hepatol

Ben Hur D, Issaschar G, Moshe R, Lebedenko B, Lujan R, Haklai Z, Weisband YL, Ben-Tov A, Lederman N, Matz E, Dotan I, Turner D, Pinto GD, Waterman M

doi: 10.1016/j.cgh.2025.01.020

Hepatology

Influence of comorbidities on health-related quality of life in alcohol-related liver disease: a population-based survey

Clin Gastroenterol Hepatol

Elde KD, Jepsen P, Von Wowern N, Winther-Jensen M, Eliasen MH, Christensen AI, Madsen LG, Askgaard G

doi: 10.1016/j.cgh.2024.09.035

Related content

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk

Association of Food Insecurity with the Prevalence and Liver-related Mortality of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Effectiveness of six international guidelines using FIB-4 and FibroScan for risk stratification of MASLD in type 2 diabetes

Primary liver cancer risk and mortality in patients with alcohol-related cirrhosis in England and Denmark: observational cohort studies

Impact of MASLD and associated comorbidities on Cognitive and Health-related Quality of Life outcomes in a Mixed MASLD-T2DM Cohort

Risk of age-related and disease-related complications and mortality in elderly-onset IBD - a population-based study

Influence of comorbidities on health-related quality of life in alcohol-related liver disease: a population-based survey